New biotech firm exploits DTU's world leading microfungal library  

MycoTeq, a biotech spin off from the Technical University of Denmark, aims to become a leading supplier of new chemical compounds developed from microfungi
MycoTeq, a new biotech spin off from the Center for Microbial Biotechnology at the Technical University of Denmark (DTU), aims to become a leading supplier of new chemical compounds developed from microfungi. MycoTeq's founders see significant potential for finding and developing compounds based on what is thought to be the world's largest microfungal library at DTU, to which MycoTeq has access.
Henrik Blou, managing director of MycoTeq says: "Our plan is to develop the individual projects to clinical phase and then sell them to a pharmaceutical company or continue development with a partner". MycoTeq has one compound in development for the treatment of elevated serum cholesterol.
The DTU collection of fungi contains more than 30,000 different strains, classified according to their secondary metabolites and their morphology. The collection is reckoned to be the best classified in the world, and the largest in certain genera (Aspergillus and Penicillium). The news was reported by financial daily newspaper Børsen.
Link > MycoTeq   

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×